Get the Stockscreener App
69.30
1.15%
0.81
Henry Schein Inc stock is traded at $69.30, with a volume of 182.60K.
It is up +1.15% in the last 24 hours and down -4.00% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
See More
Previous Close:
$68.49
Open:
$68.55
24h Volume:
182.60K
Relative Volume:
0.11
Market Cap:
$8.50B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
28.40
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
-0.14%
1M Performance:
-4.00%
6M Performance:
-3.70%
1Y Performance:
-6.68%
1-Day Range:
$67.91
$69.29
1-Week Range:
$67.69
$70.15
52-Week Range:
$63.67
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
69.30 | 8.50B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
671.82 | 84.34B | 344.58B | 2.83B | 1.63B | 21.84 |
|
COR
Cencora Inc
|
278.28 | 53.87B | 303.19B | 1.40B | -638.10M | 7.03 |
|
CAH
Cardinal Health Inc
|
137.17 | 33.56B | 222.16B | 1.31B | -486.00M | 5.36 |
|
PDCO
Patterson Companies Inc
|
31.25 | 2.75B | 6.55B | 155.22M | -823.13M | 1.71 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
IntelePeer Joins Henry Schein One API Exchange as an Authorized Integration Vendor - Bluefield Daily Telegraph
We Think Henry Schein (NASDAQ:HSIC) Can Stay On Top Of Its Debt - simplywall.st
Why Is Henry Schein (HSIC) Down 3.9% Since Last Earnings Report? - Yahoo Finance
Jefferies Adjusts Price Target on Henry Schein to $78 From $87, Keeps Hold Rating - MarketScreener
Is Henry Schein, Inc.'s (NASDAQ:HSIC) Stock Price Struggling As A Result Of Its Mixed Financials? - Yahoo Finance
Mizuho cuts Henry Schein stock price target to $76 from $78 - Investing.com Australia
Digital Revolution: Henry Schein's 3-Click Dentistry Transforms Oral Health Practice at IDS 2025 - Stock Titan
Mizuho cuts Henry Schein stock price target to $76 from $78 By Investing.com - Investing.com South Africa
Mizuho Adjusts Price Target on Henry Schein to $76 From $78, Maintains Neutral Rating - MarketScreener
Henry Schein deal cleared by UK regulators - Newsday
Insider Sell: Philip Laskawy Sells Shares of Henry Schein Inc (H - GuruFocus.com
Henry Schein Will Showcase a Selection of the Company’s Comprehensive Solutions for Oral Health Professionals at the 2025 International Dental Show - Business Wire
Major Henry Schein Stock Sales by Top Executives! - TipRanks
Henry Schein CEO Bradford Connett sells $287,161 in stock By Investing.com - Investing.com South Africa
Henry Schein director Philip Laskawy sells $184,998 in stock - Investing.com
Henry Schein director Philip Laskawy sells $184,998 in stock By Investing.com - Investing.com Australia
Henry Schein CEO Bradford Connett sells $287,161 in stock - Investing.com
Ethisphere Names Henry Schein as One of the 2024 World's Most Ethical Companies® for 13th Consecutive Year - Business Wire
TDSC.com and PDA Announce Strategic Partnership - Dentistry Today
KKR & Co reports 9.7% stake in Henry Schein as of March 10SEC Filing -March 17, 2025 at 05:34 pm EDT - Marketscreener.com
Henry Schein to Acquire a Majority Interest in Shield Healthcare, a Leading Supplier of Homecare Medical Products to Patients in the Home; Expands Henry Schein Medical’s Continuum-of-Care Delivery Model - Business Wire
Henry Schein Inc CEO NA Distribution Group Bradford Connett Sells 6,430 Shares - GuruFocus.com
Henry Schein announces executive role changes By Investing.com - Investing.com Canada
Henry Schein: These Are The 5 Biggest Challenges That Could Hinder Its Growth in Future! - Smartkarma
Henry Schein makes advance in ‘particularly attractive’ CGM market - HME News
Henry Schein, Inc. (HSIC) Announces Leadership Transition - GuruFocus.com
Henry Schein Announces Leadership Transition in 2025 - TipRanks
Henry Schein announces executive role changes - Investing.com
William Blair Decreases Earnings Estimates for Henry Schein - Defense World
Henry Schein Donations Support Special Olympics Athlete Hearing Screenings - The Hearing Review
Henry Schein, Inc. (NASDAQ:HSIC) Shares Could Be 32% Below Their Intrinsic Value Estimate - Simply Wall St
Henry Schein Donates Health Care Products to Support Special Olympics Healthy Athletes® Screenings at Special Olympics World Winter Games 2025 in Turin, Italy - Zenopa
Henry Schein recognized for Special Olympics support - HME News
Cautious Hold Rating on Henry Schein Amid New Segment Disclosures and Strategic Initiatives - TipRanks
Henry Schein at Leerink’s Conference: Strategic Growth Insights - Investing.com
Henry Schein donates health care products to support Special Olympics Healthy Athletes® screenings at Special Olympics World Winter Games 2025 in Turin, Italy - Special Olympics
Henry Schein Earns Ethical Company Award - Dentistry Today
Ethisphere Names Henry Schein as One of the 2025 World's Most Ethical Companies® for 14th Consecutive Year - Quantisnow
Henry Schein Looks Bullish (Technical Analysis) (NASDAQ:HSIC) - Seeking Alpha
Henry Schein, Inc. (NASDAQ:HSIC) Holdings Raised by Charles Schwab Investment Management Inc. - Defense World
Henry Schein, Inc. (NASDAQ:HSIC) Position Increased by Smartleaf Asset Management LLC - Defense World
Dental Implants Market Projected To Witness Substantial Growth, 2025-2032: Bicon Dental Implants, Henry Schein - EIN News
Mutual of America Capital Management LLC Sells 670 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - Defense World
Truist Financial Corp Acquires Shares of 3,710 Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
13,632 Shares in Henry Schein, Inc. (NASDAQ:HSIC) Bought by Proficio Capital Partners LLC - Defense World
Dental Implant Market Forecast Report and Company Analysis - GlobeNewswire
Dental Implant Market Forecast Report and Company Analysis 2025-2033 Featuring Danaher, Dentsply Sirona, Institut Straumann, Zimmer Biomet, Kyocera, Henry Schein, Biocon, and Osstem implant - Yahoo Finance
Director’s Big Move: Henry Schein Stock Sale Revealed! - TipRanks
LGT Group Foundation Has $20.04 Million Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Truist Financial Corp Makes New $257,000 Investment in Henry Schein, Inc. (NASDAQ:HSIC) - Defense World
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.10%
8.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):